
|Podcasts|November 13, 2012
Intrathecal Methotrexate: A Treatment Option for Patients With Progressive Multiple Sclerosis?
Author(s)Saud A. Sadiq, MD
Could intrathecally administered methotrexate be a viable treatment option for your patients with progressive forms of multiple sclerosis?
Advertisement
Could intrathecally administered methotrexate be a viable treatment option for your patients with progressive forms of multiple sclerosis?
Here to discuss the results of a study designed to test the feasibility of this therapeutic approach is neurologist Saud Sadiq. Dr Sadiq is Founder and Director of the
Dr Sadiq and his coauthors published their study in the
Intrathecal Methotrexate for Patients With MS?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
5 FDA Decisions for Primary Care to Know from July 2026
2
New CVD Risk Model Flags Heart Disease Earlier in Reproductive-Age Women
3
Why Endometriosis Diagnosis Is Often Delayed by a Decade
4
Patient AI Use and the Decline of Physician Trust, With Robert Shpiner, MD
5





























































































































































